Health Idea Now
Friday, 1 December 2017
FDA approves Mylan's biosimilar of Roche's breast cancer treatment
(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Roche's blockbuster breast cancer treatment Herceptin.
from Reuters: Health News http://ift.tt/2AjrWsn
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment